United States Government Publishing Office publisher pbl distributor dst United States Government Accountability Office author aut Government Organization text government publication eng GAOREPORTS Legislative Agency Publications gao legislative 2010-08-12 U.S. Government Printing Office 2003-01-10 monographic deposited born digital 24 p. GA 1.13:GAO-03-184 https://www.govinfo.gov/app/details/GAOREPORTS-GAO-03-184 P0b002ee18038e697 f:d03184 DGPO 2010-08-12 2011-03-24 GAOREPORTS-GAO-03-184 machine generated eng fdlp REPORT GAOREPORTS-GAO-03-184 GAO-03-184 Diseases Drugs Medical fees Cost analysis Health care costs Medicare Program Other Written Product A05837 In 2001, Medicare's outpatient expenditures for blood clotting factor used to treat the estimated 1,100 beneficiaries with hemophilia totaled about $105 million, or more than 2 percent of total Medicare spending on outpatient drugs. Earlier work by GAO indicated that Medicare's payment for certain outpatient drugs is substantially higher than providers' acquisition costs. Concerns have been raised about Medicare's payment for blood clotting factor. GAO was asked to compare provider costs of purchasing clotting factor with Medicare's payment for it and to identify costs to providers associated with delivering clotting factor. https://www.govinfo.gov/content/pkg/GAOREPORTS-GAO-03-184/html/GAOREPORTS-GAO-03-184.htm https://www.govinfo.gov/content/pkg/GAOREPORTS-GAO-03-184/pdf/GAOREPORTS-GAO-03-184.pdf GAO-03-184 https://www.govinfo.gov/app/details/GAOREPORTS-GAO-03-184 Other Written Product GAO-03-184; Medicare: Payment for Blood Clotting Factor Exceeds Providers' Acquisition Cost; Diseases Drugs Medical fees Cost analysis Health care costs Medicare Program Volume 89 Page 304 89 Stat. 304 Volume 106 Page 4943 106 Stat. 4943 Public Law 94-63 Public Law 102-585